Inteligex is a healthcare that provides molecular therapies for patients to treat spinal cord injury &a; diseases of the central nervous.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Toronto
State: Ontario
Zip:
Country: Canada
Inteligex is developing proprietary stem cell-based therapeutics to restore function in patients with spinal cord injury— a devastating condition for which there is no effective therapy — and for other diseases of the Central Nervous System. Successful outcomes from the development program would position Inteligex as the first in the world with a treatment affecting hundreds of thousand patients worldwide.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Pre Seed Round | 1 | - |
UTEST UTEST |
1/2021 | Non Equity Assistance | 1 | - |
Creative Destruction Lab (CDL) Creative Destruction Lab (CDL) |
9/2020 | Grant | 2 | - |
Ontario Brain Institute University of Toronto Ontario Brain Institute University of Toronto |
1/2021 | Non Equity Assistance | 1 | - |
Creative Destruction Lab (CDL) Creative Destruction Lab (CDL) |
9/2020 | Grant | 2 | - |
Ontario Brain Institute University of Toronto Ontario Brain Institute University of Toronto |
1/2019 | Pre Seed Round | 1 | - |
UTEST UTEST |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|